Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

1.

Is "pelvic radiation disease" always the cause of bowel symptoms following prostate cancer intensity-modulated radiotherapy?

Min M, Chua B, Guttner Y, Abraham N, Aherne NJ, Hoffmann M, McKay MJ, Shakespeare TP.

Radiother Oncol. 2014 Feb;110(2):278-83. doi: 10.1016/j.radonc.2013.11.012. Epub 2014 Jan 8.

PMID:
24412017
[PubMed - indexed for MEDLINE]
2.

Toxicity assessment of pelvic intensity-modulated radiotherapy with hypofractionated simultaneous integrated boost to prostate for intermediate- and high-risk prostate cancer.

McCammon R, Rusthoven KE, Kavanagh B, Newell S, Newman F, Raben D.

Int J Radiat Oncol Biol Phys. 2009 Oct 1;75(2):413-20. doi: 10.1016/j.ijrobp.2008.10.050. Epub 2009 Apr 11.

PMID:
19362783
[PubMed - indexed for MEDLINE]
3.

Combination of dose escalation with technological advances (intensity-modulated and image-guided radiotherapy) is not associated with increased morbidity for patients with prostate cancer.

Pinkawa M, Piroth MD, Holy R, Djukic V, Klotz J, Krenkel B, Eble MJ.

Strahlenther Onkol. 2011 Aug;187(8):479-84. doi: 10.1007/s00066-011-2249-z. Epub 2011 Jul 25.

PMID:
21789739
[PubMed - indexed for MEDLINE]
4.

Analysis of toxicity in patients with high risk prostate cancer treated with intensity-modulated pelvic radiation therapy and simultaneous integrated dose escalation to prostate area.

Arcangeli S, Saracino B, Petrongari MG, Gomellini S, Marzi S, Landoni V, Gallucci M, Sperduti I, Arcangeli G.

Radiother Oncol. 2007 Aug;84(2):148-55. Epub 2007 Aug 9.

PMID:
17692416
[PubMed - indexed for MEDLINE]
5.

Influence of organ motion on conformal vs. intensity-modulated pelvic radiotherapy for prostate cancer.

Hysing LB, Skorpen TN, Alber M, Fjellsbø LB, Helle SI, Muren LP.

Int J Radiat Oncol Biol Phys. 2008 Aug 1;71(5):1496-503. doi: 10.1016/j.ijrobp.2008.04.011. Epub 2008 Jun 4.

PMID:
18538493
[PubMed - indexed for MEDLINE]
6.

Outcomes after intensity-modulated versus conformal radiotherapy in older men with nonmetastatic prostate cancer.

Bekelman JE, Mitra N, Efstathiou J, Liao K, Sunderland R, Yeboa DN, Armstrong K.

Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e325-34. doi: 10.1016/j.ijrobp.2011.02.006. Epub 2011 Apr 16.

PMID:
21498008
[PubMed - indexed for MEDLINE]
Free PMC Article
7.
8.

Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer.

Zelefsky MJ, Kollmeier M, Cox B, Fidaleo A, Sperling D, Pei X, Carver B, Coleman J, Lovelock M, Hunt M.

Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):125-9. doi: 10.1016/j.ijrobp.2011.11.047. Epub 2012 Feb 11.

PMID:
22330997
[PubMed - indexed for MEDLINE]
9.

Phase I trial of pelvic nodal dose escalation with hypofractionated IMRT for high-risk prostate cancer.

Adkison JB, McHaffie DR, Bentzen SM, Patel RR, Khuntia D, Petereit DG, Hong TS, Tomé W, Ritter MA.

Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):184-90. doi: 10.1016/j.ijrobp.2010.09.018. Epub 2010 Dec 14.

PMID:
21163590
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Reduced acute bowel toxicity in patients treated with intensity-modulated radiotherapy for rectal cancer.

Samuelian JM, Callister MD, Ashman JB, Young-Fadok TM, Borad MJ, Gunderson LL.

Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):1981-7. doi: 10.1016/j.ijrobp.2011.01.051. Epub 2011 Apr 7.

PMID:
21477938
[PubMed - indexed for MEDLINE]
11.

Image-guided dose-escalated intensity-modulated radiation therapy for prostate cancer: treating to doses beyond 78 Gy.

Eade TN, Guo L, Forde E, Vaux K, Vass J, Hunt P, Kneebone A.

BJU Int. 2012 Jun;109(11):1655-60. doi: 10.1111/j.1464-410X.2011.10668.x. Epub 2011 Oct 28.

PMID:
22035373
[PubMed - indexed for MEDLINE]
12.

Improvement in toxicity in high risk prostate cancer patients treated with image-guided intensity-modulated radiotherapy compared to 3D conformal radiotherapy without daily image guidance.

Sveistrup J, af Rosenschöld PM, Deasy JO, Oh JH, Pommer T, Petersen PM, Engelholm SA.

Radiat Oncol. 2014 Feb 4;9:44. doi: 10.1186/1748-717X-9-44.

PMID:
24495815
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Clinical application of high-dose, image-guided intensity-modulated radiotherapy in high-risk prostate cancer.

Bayley A, Rosewall T, Craig T, Bristow R, Chung P, Gospodarowicz M, Ménard C, Milosevic M, Warde P, Catton C.

Int J Radiat Oncol Biol Phys. 2010 Jun 1;77(2):477-83. doi: 10.1016/j.ijrobp.2009.05.006. Epub 2009 Sep 3.

PMID:
19733014
[PubMed - indexed for MEDLINE]
14.

Toxicity after intensity-modulated, image-guided radiotherapy for prostate cancer.

Guckenberger M, Ok S, Polat B, Sweeney RA, Flentje M.

Strahlenther Onkol. 2010 Oct;186(10):535-43. doi: 10.1007/s00066-010-2144-z. Epub 2010 Sep 30. Erratum in: Strahlenther Onkol. 2010 Dec;186(12):705.

PMID:
20890743
[PubMed - indexed for MEDLINE]
15.

Whole pelvic radiotherapy for prostate cancer using 3D conformal and intensity-modulated radiotherapy.

Ashman JB, Zelefsky MJ, Hunt MS, Leibel SA, Fuks Z.

Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):765-71.

PMID:
15913914
[PubMed - indexed for MEDLINE]
16.

Comparative toxicity and dosimetric profile of whole-pelvis versus prostate bed-only intensity-modulated radiation therapy after prostatectomy.

Deville C, Vapiwala N, Hwang WT, Lin H, Ad VB, Tochner Z, Both S.

Int J Radiat Oncol Biol Phys. 2012 Mar 15;82(4):1389-96. doi: 10.1016/j.ijrobp.2011.04.041. Epub 2011 Jun 12.

PMID:
21664069
[PubMed - indexed for MEDLINE]
17.

Dose-volume relationships for acute bowel toxicity in patients treated with pelvic nodal irradiation for prostate cancer.

Fiorino C, Alongi F, Perna L, Broggi S, Cattaneo GM, Cozzarini C, Di Muzio N, Fazio F, Calandrino R.

Int J Radiat Oncol Biol Phys. 2009 Sep 1;75(1):29-35. doi: 10.1016/j.ijrobp.2008.10.086. Epub 2009 May 19.

PMID:
19467803
[PubMed - indexed for MEDLINE]
18.

Bile acid malabsorption after pelvic and prostate intensity modulated radiation therapy: an uncommon but treatable condition.

Harris V, Benton B, Sohaib A, Dearnaley D, Andreyev HJ.

Int J Radiat Oncol Biol Phys. 2012 Dec 1;84(5):e601-6. doi: 10.1016/j.ijrobp.2012.07.2368. Epub 2012 Sep 18.

PMID:
22995663
[PubMed - indexed for MEDLINE]
19.

Intensity-modulated radiotherapy allows escalation of the radiation dose to the pelvic lymph nodes in patients with locally advanced prostate cancer: preliminary results of a phase I dose escalation study.

Guerrero Urbano T, Khoo V, Staffurth J, Norman A, Buffa F, Jackson A, Adams E, Hansen V, Clark C, Miles E, McNair H, Nutting C, Parker C, Eeles R, Huddart R, Horwich A, Dearnaley DP.

Clin Oncol (R Coll Radiol). 2010 Apr;22(3):236-44. doi: 10.1016/j.clon.2010.01.005. Epub 2010 Feb 19.

PMID:
20171852
[PubMed - indexed for MEDLINE]
20.

Intensity-modulated radiotherapy improves lymph node coverage and dose to critical structures compared with three-dimensional conformal radiation therapy in clinically localized prostate cancer.

Wang-Chesebro A, Xia P, Coleman J, Akazawa C, Roach M 3rd.

Int J Radiat Oncol Biol Phys. 2006 Nov 1;66(3):654-62.

PMID:
17011444
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk